Vaccine News and Research

Latest Vaccine News and Research

Researchers reveal potential of multivalent antibodies for HIV prevention, treatment and cure

The ability of HIV to mutate has been a major challenge to vaccine development. As the body produces antibodies to target the outer HIV envelope protein, this protein changes, thwarting the circulating antibodies' ability to neutralize it.

18 Jan 2018

New vaccine approach offers effective protection against tuberculosis

A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

18 Jan 2018

World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows

Around 400 million people world-wide suffer in some form or other from a grass pollen allergy (rhinitis) - with the usual symptoms such as a runny nose, cough and severe breathing problems.

18 Jan 2018

Measles outbreak alarms public health officials

According to the Public Health England (PHE) there are “large outbreaks” of measles in Europe that is cause for concern.

16 Jan 2018

New universal flu vaccine moves to clinical trial phase and could be a reality soon

Alphabet’s venture arm called Google Ventures earlier is one of the supporters of a mega projects that is developing a vaccine for flu that is safe and effective. Vaccitech from United Kingdom is working towards development of the vaccine and Alphabet has shown its support by contributing $27.6 million in new funding. The funds would be used conduct clinical trials and try the new vaccine.

16 Jan 2018

Past exposures influence immune response in children with acute respiratory tract infections

Acute respiratory tract infections (ARTI) are the leading global cause of death in early childhood, according to the Centers for Disease Control and Prevention.

12 Jan 2018

Early testing for influenza symptoms can limit severe, life-threatening disease

As flu season picks up steam across the country, it's important for people to be tested very early after symptoms that are compatible with influenza start, since there are effective treatments that can limit severe, life-threatening disease and curtail transmission to others.

12 Jan 2018

Researchers discover new weapon to combat tuberculosis

Tuberculosis (TB), an infectious disease which attacks the lungs, claims someone's life every 20 seconds and 1.5 million lives worldwide every year.

11 Jan 2018

Study reveals how dengue virus replicates without triggering the body's defenses

A new study reveals how dengue virus manages to reproduce itself in an infected person without triggering the body's normal defenses. Duke researchers report that dengue pulls off this hoax by co-opting a specialized structure within host cells for its own purposes, like a lazy roommate sneaking bits of his laundry into the communal wash.

11 Jan 2018

New report shows little improvement in survival among young adults with cancer

Outcomes for children and older adults with cancer have improved greatly over the past three decades, but there's been little improvement in survival among adolescents and young adults with cancer.

10 Jan 2018

Dumfries and Galloway reassures people over number of “Aussie flu” cases

NHS Dumfries and Galloway has reassured the public over the number of “Aussie flu” cases seen in the region, saying that the H3N2 flu strain is a standard one that has previously been commonplace in Scotland.

9 Jan 2018

Cedars-Sinai expert discusses ways to keep healthy as flu activity surges

Jonathan Grein, MD, Cedars-Sinai medical director of Hospital Epidemiology, is available to discuss ways to keep healthy as flu activity surges dramatically.

8 Jan 2018

Saliva-based diagnostics offer possibility to detect HPV-induced throat cancer

This follows the extension of a QUT collaboration with Johnson & Johnson Innovation, Janssen Vaccines & Prevention, and Janssen Cilag Pty Ltd.

8 Jan 2018

Grassley calls for ‘corrective action’ on abuses in herpes vaccine research

A Republican senator is demanding that the Trump administration and a university scrutinize how a researcher was able to inject an experimental herpes vaccine into human subjects without routine safety oversight.

5 Jan 2018

New research hub set up to help stop future outbreaks of killer diseases

A ground-breaking new research hub has been set up to help halt future outbreaks of killer diseases like Ebola and Zika.

3 Jan 2018

Researchers identify cholera hotspots at Uganda's borders and lakes

Uganda is among the countries is sub-Saharan Africa where cholera remains a recurring problem, despite advances in science and technology for prevention, detection and treatment of the infectious disease.

29 Dec 2017

UCLA expert suggests measures for reducing risk of getting sick during holiday travel

It's that time of year when families jet off to all parts of the country – and the globe - to share some holiday cheer. Unfortunately, all that travel forces people into often-crowded airplanes, automobiles and airports. And there's the sharing of hugs and kisses with loved ones upon arrival at their destination.

28 Dec 2017

Nanobiotix receives FDA approval for first immuno-oncology trial

NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).

26 Dec 2017

Zika pandemic remains formidable challenge to medicine and public health, say experts

Since 2016, when Zika was declared by the World Health Organization as a public health emergency of international concern, the virus has become established in more than 80 countries, infected millions of people, and left many babies with birth defects (collectively called congenital Zika syndrome).

22 Dec 2017

T cell-inducing dengue vaccines could confer broader protection for kids born to vaccinated mothers

For a long time, a dengue vaccine was the holy grail in dengue research. Now that a dengue vaccine is finally on the market (Sanofi's Dengvaxia), other issues have arisen, such as what happens in the babies of vaccinated mothers.

22 Dec 2017